Change - Announcement of Appointment::Appointment of Chief Financial Officer

Issuer & Securities

Issuer/ Manager
MOOREAST HOLDINGS LTD.
Securities
MOOREAST HOLDINGS LTD. - SGXE69578966 - 1V3
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
01-Oct-2024 18:22:54
Status
New
Announcement Sub Title
Appointment of Chief Financial Officer
Announcement Reference
SG241001OTHRFC8V
Submitted By (Co./ Ind. Name)
Sim Koon Lam
Designation
Executive Director, CEO and Deputy Chairman
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr Siu Yeung Sau ("Mr Siu") as Chief Financial Officer of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, W Capital Markets Pte. Ltd. (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Alicia Chang, Registered Professional, W Capital Markets Pte. Ltd., 65 Chulia Street, #43-01 OCBC Centre, Singapore 049513, Telephone (65) 6513 3525.

Additional Details

Date Of Appointment
01/10/2024
Name Of Person
Siu Yeung Sau
Age
51
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Nominating Committee had reviewed, assessed and concluded that Mr Siu possesses the requisite qualifications and work experiences. On the recommendation of the Nominating Committee, the Board has approved the appointment of Mr Siu as a Chief Financial Officer of the Company.
Whether appointment is executive, and if so, the area of responsibility
Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Professional qualifications
Master of Business Administration - California State University, East Bay;

Bachelor of Accountancy - Nanyang Technological University;

Chartered Accountant (Singapore) - Institute of Singapore Chartered Accountants
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
June 2022 - May 2024 - Financial Controller of Biolidics Limited

Mar 2019 - Apr 2022 - Director, Finance & Corporate Planning of Mount Faber Leisure group

Aug 2017 - Mar 2019 - Chief Financial Officer of Mary Chia Holdings Limited

Jul 2012 - Sep 2015 - Chief Financial officer of EuroSports Global Limited
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
Nil
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
Yes
If Yes, Please provide full details
Prior to Mr Siu's appointment as the Chief Financial Officer of Mary Chia Holdings Limited ("Mary Chia") in August 2017, Mary Chia and its joint venture partner were instructed by the Singapore International Arbitration Centre on 7 July 2017 to take steps to liquidate their joint venture company, MSB Beauty Pte Ltd ("MSB"). The liquation process of MSB had commenced after Mr Siu's appointment as the CFO of Mary Chia. Please refer to Mary Chia's announcement dated 13 July 2018 for further details.

Subsequent to Mr Siu's cessation as the Financial Controller of Biolidics Limited ("Biolidics"), Biolidics has on 10 June 2024 announced that Biolidics will be placing its wholly owned subsidiary, Biomedics Laboratory Pte. Ltd. into creditors voluntary liquidation. Please refer to Biolidics' announcement dated 10 June 2024 for further details.
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Not applicable